Cargando…

Mechanistic Analysis of the Broad Antiretroviral Resistance Conferred by HIV-1 Envelope Glycoprotein Mutations

Despite the effectiveness of antiretroviral (ARV) therapy, virological failure can occur in some HIV-1-infected patients in the absence of mutations in drug target genes. We previously reported that, in vitro, the lab-adapted HIV-1 NL4-3 strain can acquire resistance to the integrase inhibitor dolut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hikichi, Yuta, Van Duyne, Rachel, Pham, Phuong, Groebner, Jennifer L., Wiegand, Ann, Mellors, John W., Kearney, Mary F., Freed, Eric O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844542/ https://www.ncbi.nlm.nih.gov/pubmed/33436439 http://dx.doi.org/10.1128/mBio.03134-20

Ejemplares similares

Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies
por: Gnanakaran, S., et al.
Publicado: (2010)

A Mechanistic Understanding of Allosteric Immune Escape Pathways in the HIV-1 Envelope Glycoprotein
por: Sethi, Anurag, et al.
Publicado: (2013)

A broad HIV-1 inhibitor blocks envelope glycoprotein transitions critical for entry
por: Herschhorn, Alon, et al.
Publicado: (2014)

THE VIRAL ENVELOPE GLYCOPROTEIN OF MURINE LEUKEMIA VIRUS AND THE PATHOGENESIS OF IMMUNE COMPLEX GLOMERULONEPHRITIS OF NEW ZEALAND MICE
por: Yoshiki, Takashi, et al.
Publicado: (1974)

Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models
por: Lacerda, Miguel, et al.
Publicado: (2013)

Envelope Glycoprotein of Arenaviruses
por: Burri, Dominique J., et al.
Publicado: (2012)

Temsavir Treatment of HIV-1-Infected Cells Decreases Envelope Glycoprotein Recognition by Broadly Neutralizing Antibodies
por: Boutin, Marianne, et al.
Publicado: (2022)

Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted / founder sensitivity to broadly neutralizing antibodies
por: Ratnapriya, Sneha, et al.
Publicado: (2023)

Global Rescue of Defects in HIV-1 Envelope Glycoprotein Incorporation: Implications for Matrix Structure
por: Tedbury, Philip R., et al.
Publicado: (2013)

Membrane Glycoproteins of Enveloped Viruses
por: Compans, Richard W., et al.
Publicado: (1978)

Mechanistic Insight into Bunyavirus-Induced Membrane Fusion from Structure-Function Analyses of the Hantavirus Envelope Glycoprotein Gc
por: Guardado-Calvo, Pablo, et al.
Publicado: (2016)

Immunotherapy-induced antibodies to endogenous retroviral envelope glycoprotein confer tumor protection in mice
por: Kang, Byong H., et al.
Publicado: (2021)

IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein
por: Yu, Jingyou, et al.
Publicado: (2015)

A38 Diversity analyses of HIV-1 envelope glycoproteins in HIV-infected individuals with and without broadly neutralizing antibodies
por: Mabvakure, B., et al.
Publicado: (2017)

Envelope glycoprotein interactions in coronavirus assembly
Publicado: (1995)

HCMV Envelope Glycoprotein Diversity Demystified
por: Foglierini, Mathilde, et al.
Publicado: (2019)

V5 region in the HIV-1 envelope glycoprotein determines viral sensitivity to the broadly neutralizing monoclonal antibody VRC01
por: Guo, D, et al.
Publicado: (2012)

Structures and Functions of the Envelope Glycoprotein in Flavivirus Infections
por: Zhang, Xingcui, et al.
Publicado: (2017)

Glycan shield of the ebolavirus envelope glycoprotein GP
por: Peng, Weiwei, et al.
Publicado: (2022)

Rationally designed HIV envelope glycoproteins delivered in a novel adjuvant elicited more broadly reactive antigen-specific antibody responses
por: Dey, AK, et al.
Publicado: (2012)

The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
por: Gandhi, Rajesh T., et al.
Publicado: (2010)

Correction: The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
por: Gandhi, Rajesh T., et al.
Publicado: (2011)

Apoptosis of uninfected cells induced by HIV envelope glycoproteins
por: Ahr, Barbara, et al.
Publicado: (2004)

Dynamic electrophoretic fingerprinting of the HIV-1 envelope glycoprotein
por: Stieh, Daniel J, et al.
Publicado: (2013)

Envelope Glycoprotein Trimers as HIV-1 Vaccine Immunogens
por: Sattentau, Quentin J.
Publicado: (2013)

Coevolution Analysis of HIV-1 Envelope Glycoprotein Complex
por: Rawi, Reda, et al.
Publicado: (2015)

Structural Transitions of the Conserved and Metastable Hantaviral Glycoprotein Envelope
por: Rissanen, Ilona, et al.
Publicado: (2017)

HIV and SIV Envelope Glycoproteins Interact with Glycolipids and Lipids
por: Planes, Rémi, et al.
Publicado: (2023)

HIV-1 Envelope Glycoprotein Variable Loops Are Indispensable for Envelope Structural Integrity and Virus Entry
por: Yuan, Tingting, et al.
Publicado: (2013)

Helical ordering of envelope‐associated proteins and glycoproteins in respiratory syncytial virus
por: Conley, Michaela J, et al.
Publicado: (2021)

Novel broad spectrum virucidal molecules against enveloped viruses
por: Cagno, Valeria, et al.
Publicado: (2018)

Palmitoylation of the feline immunodeficiency virus envelope glycoprotein and its effect on fusion activity and envelope incorporation into virions
por: González, Silvia A., et al.
Publicado: (2012)

Requirements for the insertion of the Sindbis envelope glycoproteins into the endoplasmic reticulum membrane
Publicado: (1979)

Structural Mechanism of Trimeric HIV-1 Envelope Glycoprotein Activation
por: Tran, Erin E. H., et al.
Publicado: (2012)

Molecular architecture of the uncleaved HIV-1 envelope glycoprotein trimer
por: Mao, Youdong, et al.
Publicado: (2013)

Correction: Coevolution Analysis of HIV-1 Envelope Glycoprotein Complex
por: Rawi, Reda, et al.
Publicado: (2015)

Antigenicity of peptides comprising the immunosuppressive domain of the retroviral envelope glycoprotein
por: Jenkins, Bryony, et al.
Publicado: (2017)

Stabilized HIV-1 envelope glycoprotein trimers for vaccine use
por: Medina-Ramírez, Max, et al.
Publicado: (2017)

An entry-competent intermediate state of the HIV-1 envelope glycoproteins
por: Herschhorn, Alon, et al.
Publicado: (2017)

Immunogenicity and efficacy of Schmallenberg virus envelope glycoprotein subunit vaccines
por: Endalew, Abaineh D., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4bj8vi47p4a90qngakelafmfkv